WASHINGTON, D.C. – Today, America First Legal (AFL) launched a new investigation into the U.S. Food and Drug Administration (FDA) following a shocking discovery through litigation that revealed the FDA’s Division of General Endocrinology recommended the FDA approve puberty blockers for children despite direct knowledge that these drugs increase the risk of depression and suicidality.

Despite the trend in Europe to change course amidst a clear social contagion, the risks of transitioning children socially and medically, and the growing population of detransitioners, the Biden-Harris Administration is taking an approach diametrically opposed to the trends in Europe and shocking evidence in the United States.

To better understand the FDA’s activities with respect to the off-label use of puberty blockers in children, particularly as it relates to increased risk of suicide and depression, AFL has filed a Freedom of Information Act (FOIA) request with the FDA to obtain additional details surrounding this disturbing discovery.

Read the FOIA here.

Photo Credits: Adobe Stock Images / BillionPhotos.com